David Ozog, MD
MOHS-Micrographic Surgery · Detroit, MINPI 1083792113
Payments from drug & device makers
What this record shows
This record is dominated by grants: $21,428 of the $21,967 with a category attached, or 97.5%. Galderma Laboratories, L.p. accounts for 99.0% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2019 at $14,267 and has fallen 98.9% since, to $155 in 2025. Among mohs-micrographic surgery clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 12 payments — averaging $1830.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$22K
- AbbVie$176
- Novartis$50
Across 13 payments — averaging $19,526 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biofrontera Inc.$244K
- Biofrontera Bioscience GmbH$10K
What the payments were for
- Grants$21,42898%
- Food & beverage$5382%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 7 | $21,740 |
| AbbVie | 4 | $176 |
| Novartis | 1 | $50 |
How this compares
$21,967 in reported general payments places this provider in the 95th percentile of 30 mohs-micrographic surgery providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 41 | $142 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Detroit
- Bryan SofenRoyal Oak$35K
- Michael WhitworthWyandotte$13K
- David ByrdRochester Hills$10K
- Ryan JonesPortage$9K
- Abraham AbdulhakDearborn$8K
- Lindsay SklarWest Bloomfield$6K
- Luke NicholasRockford$4K
- Syed HamzaviClinton Twp$4K
- Aaron CetnerWest Bloomfield$3K
- Ayad AbrouRochester Hills$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.